Systematic review of randomized clinical trials on the use of hydroxyethyl starch for fluid management in sepsis

BMC Emergency Medicine

Volumn 8, Issue , 2008, Pages

  Wiedermann, Christian J ^a  

^a CENTRAL HOSPITAL OF BOLZANO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; GELATIN; HETASTARCH;

ACUTE KIDNEY FAILURE; CARDIOPULMONARY HEMODYNAMICS; CLINICAL TRIAL; COCHRANE LIBRARY; CONTROLLED CLINICAL TRIAL; CRYSTALLOID; DRUG EFFICACY; DRUG SAFETY; EMBASE; FLUID RESUSCITATION; FLUID THERAPY; HUMAN; MEDLINE; META ANALYSIS; NONHUMAN; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEPSIS; SEPTIC SHOCK; SURVIVAL RATE; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT INDICATION;

EID: 39549099713     PISSN: None     EISSN: 1471227X     Source Type: Journal    
DOI: 10.1186/1471-227X-8-1     Document Type: Review

References (51)

1. Gong MN Thompson BT Williams P Pothier L Boyce PD Christiani DC Clinical predictors of and mortality in acute respiratory distress syndrome: potential role of red cell transfusion Crit Care Med 2005, 33:1191-1198 10.1097/01.CCM.0000165566.82925.14 15942330
2. Pittet D Thievent B Wenzel RP Li N Auckenthaler R Suter PM Bedside prediction of mortality from bacteremic sepsis. A dynamic analysis of ICU patients Am J Respir Crit Care Med 1996, 153:684-693 8564118
3. Weycker D Akhras KS Edelsberg J Angus DC Oster G Long-term mortality and medical care charges in patients with severe sepsis Crit Care Med 2003, 31:2316-2323 10.1097/01.CCM.0000085178.80226.0B 14501962
4. Yu DT Platt R Lanken PN Black E Sands KE Schwartz JS Hibberd PL Graman PS Kahn KL Snydman DR Parsonnet J Moore R Bates DW Relationship of pulmonary artery catheter use to mortality and resource utilization in patients with severe sepsis Crit Care Med 2003, 31:2734-2741 10.1097/ 01.CCM.0000098028.68323.64 14668609
5. Braun L Riedel AA Cooper LM Severe sepsis in managed care: Analysis of incidence, one-year mortality, and associated costs of care J Manag Care Pharm 2004, 10:521-530 15548124
6. van Biesen W Yegenaga I Vanholder R Verbeke F Hoste E Colardyn F Lameire N Relationship between fluid status and its management on acute renal failure (ARF) in intensive care unit (ICU) patients with sepsis: A prospective analysis J Nephrol 2005, 18:54-60 15772923
7. Rackow EC Mecher C Astiz ME Griffel M Falk JL Weil MH Effects of pentastarch and albumin infusion on cardiorespiratory function and coagulation in patients with severe sepsis and systemic hypoperfusion Crit Care Med 1989, 17:394-398 2468447
8. Brun-Buisson C Doyon F Carlet J Dellamonica P Gouin F Lepoutre A Mercier JC Offenstadt G Régnier B Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis JAMA 1995, 274:968-974 10.1001/jama.274.12.968 7674528
9. Falk JL Rackow EC Astiz ME Weil MH Effects of hetastarch and albumin on coagulation in patients with septic shock J Clin Pharmacol 1988, 28:412-415 2455740
10. Groeneveld AB Bronsveld W Thijs LG Hemodynamic determinants of mortality in human septic shock Surgery 1986, 99:140-153 3511560
11. Marik PE Iglesias J Would the colloid detractors please sit down! Crit Care Med 2000, 28:2652-2654 10.1097/00003246-200007000-00083 10921614
12. Mangialardi RJ Martin GS Bernard GR Wheeler AP Christman BW Dupont WD Higgins SB Swindell BB Hypoproteinemia predicts acute respiratory distress syndrome development, weight gain, and death in patients with sepsis. Ibuprofen in Sepsis Study Group Crit Care Med 2000, 28:3137-3145 10.1097/00003246-200009000-00001 11008971
13. Schortgen F Deye N Brochard L Preferred plasma volume expanders for critically ill patients: Results of an international survey Intensive Care Med 2004, 30:2222-2229 10.1007/s00134-004-2415-1 15452693
14. Treib J Haass A Pindur G Seyfert UT Treib W Grauer MT Jung F Wenzel E Schimrigk K HES 200/0.5 is not HES 200/0.5. Influence of the C2/C6 hydroxyethylation ratio of hydroxyethyl starch (HES) on hemorheology, coagulation and elimination kinetics Thromb Haemost 1995, 74:1452-1456 8772219
15. Vincent JL Fluid management: The pharmacoeconomic dimension Crit Care 2000, 4(Suppl 2):S33-35 11255597
16. Wiedermann CJ Hydroxyethyl starch-can the safety problems be ignored? Wien Klin Wochenschr 2004, 116:583-594 10.1007/s00508-004-0237-3 15515874
17. Boldt J Heesen M Welters I Padberg W Martin K Hempelmann G Does the type of volume therapy influence endothelial-related coagulation in the critically ill? Br J Anaesth 1995, 75:740-746 8672323
18. Boldt J Müller M Heesen M Heyn O Hempelmann G Influence of different volume therapies on platelet function in the critically ill Intensive Care Med 1996, 22:1075-1081 10.1007/BF01699231 8923073
19. Boldt J Heesen M Müller M Pabsdorf M Hempelmann G The effects of albumin versus hydroxyethyl starch solution on cardiorespiratory and circulatory variables in critically ill patients Anesth Analg 1996, 83:254-261 10.1097/00000539-199608000-00010 8694302
20. Boldt J Müller M Heesen M Neumann K Hempelmann GG Influence of different volume therapies and pentoxifylline infusion on circulating soluble adhesion molecules in critically ill patients Crit Care Med 1996, 24:385-391 10.1097/00003246-199603000-00005 8625624
21. Boldt J Mueller M Menges T Papsdorf M Hempelmann G Influence of different volume therapy regimens on regulators of the circulation in the critically ill Br J Anaesth 1996, 77:480-487 8942332
22. Boldt J Müller M Mentges D Papsdorf M Hempelmann G Volume therapy in the critically ill: Is there a difference? Intensive Care Med 1998, 24:28-36 10.1007/s001340050511 9503219
23. Asfar P Kerkeni N Labadie F Gouëllo JP Brenet O Alquier P Assessment of hemodynamic and gastric mucosal acidosis with modified fluid versus 6% hydroxyethyl starch: A prospective, randomized study Intensive Care Med 2000, 26:1282-1287 10.1007/s001340000606 11089754
24. Schortgen F Lacherade JC Bruneel F Cattaneo I Hemery F Lemaire F Brochard L Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: A multicentre randomised study Lancet 2001, 357:911-916 10.1016/S0140-6736(00)04211-2 11289347
25. Molnár Z Mikor A Leiner T Szakmány T Fluid resuscitation with colloids of different molecular weight in septic shock Intensive Care Med 2004, 30:1356-1360 10.1007/s00134-004-2278-5 15127186
26. Palumbo D Servillo G D'Amato L Volpe ML Capogrosso G De Robertis E Piazza O Tufano R The effects of hydroxyethyl starch solution in critically ill patients Minerva Anestesiol 2006, 72:655-664 16865084
27. Brunkhorst FM Engel C Bloos F Meier-Hellmann A Ragaller M Weiler N Moerer O Gruendling M Oppert M Grond S Olthoff D Jaschinski U John S Rossaint R Welte T Schaefer M Kern P Kuhnt E Kiehntopf M Hartog C Natanson C Loeffler M Reinhart K Intensive insulin therapy and pentastarch resuscitation in severe sepsis. The German Competence Network Sepsis (SepNet) N Engl J Med 2008, 358:125-139 10.1056/ NEJMoa070716 18184958
28. Haupt MT Rackow EC Colloid osmotic pressure and fluid resuscitation with hetastarch, albumin, and saline solutions Crit Care Med 1982, 10:159-162 10.1097/00003246-198203000-00004 6174274
29. Rackow EC Falk JL Fein IA Siegel JS Packman MI Haupt MT Kaufman BS Putnam D Fluid resuscitation in circulatory shock: A comparison of the cardiorespiratory effects of albumin, hetastarch, and saline solutions in patients with hypovolemic and septic shock Crit Care Med 1983, 11:839-850 10.1097/00003246-198311000-00001 6194934
30. Veneman TF Oude Nijhuis J Woittiez AJ Human albumin and starch administration in critically ill patients: A prospective randomized clinical trial Wien Klin Wochenschr 2004, 116:305-309 15237655
31. Boldt J Knothe C Schindler E Hammermann H Dapper F Hempelmann G Volume replacement with hydroxyethyl starch solution in children Br J Anaesth 1993, 70:661-665 10.1093/bja/70.6.661 7687142
32. Kumle B Boldt J Piper S Schmidt C Suttner S Salopek S The influence of different intravascular volume replacement regimens on renal function in the elderly Anesth Analg 1999, 89:1124-1130 10.1097/ 00000539-199911000-00009 10553822
33. Cittanova ML Leblanc I Legendre C Mouquet C Riou B Coriat P Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients Lancet 1996, 348:1620-1622 10.1016/ S0140-6736(96)07588-5 8961992
34. SAFE Study Investigators A comparison of albumin and saline for fluid resuscitation in the intensive care unit N Engl J Med 2004, 350:2247-2256 10.1056/NEJMoa040232 15163774
35. Castro VJ Astiz ME Rackow EC Effect of crystalloid and colloid solutions on blood rheology in sepsis Shock 1997, 8:104-107 10.1097/ 00024382-199708000-00007 9261899
36. Paes-da-Silva F Gonzalez AP Tibiriçá E Effects of fluid resuscitation on mesenteric microvascular blood flow and lymphatic activity after severe hemorrhagic shock in rats Shock 2003, 19:55-60 10.1097/00024382-200301000-00011 12558145
37. Schildt B Bouveng R Sollenberg M Plasma substitute induced impairment of the reticuloendothelial system function Acta Chir Scand 1975, 141:7-13 1092112
38. Thompson WL Fukushima T Rutherford RB Walton RP Intravascular persistence, tissue storage, and excretion of hydroxyethyl starch Surg Gynecol Obstet 1970, 131:965-972 5471548
39. Pfeifer U Kult J Forster H Ascites als Komplikation hepatischer Speicherung von Hydroxyethylstärke (HES) bei Langzeitdialyse Klin Wochenschr 1984, 62:862-866 10.1007/BF01712005 6208407
40. Dienes HP Gerharz CD Wagner R Weber M John HD Accumulation of hydroxyethyl starch (HES) in the liver of patients with renal failure and portal hypertension J Hepatol 1986, 3:223-227 10.1016/ S0168-8278(86)80030-7 2432110
41. Jurecka W Szepfalusi Z Parth E Schimetta W Gebhart W Scheiner O Kraft D Hydroxyethylstarch deposits in human skin - a model for pruritus? Arch Dermatol Res 1993, 285:13-19 10.1007/BF00370817 7682398
42. Auwerda JJ Wilson JH Sonneveld P Foamy macrophage syndrome due to hydroxyethyl starch replacement: A severe side effect in plasmapheresis Ann Intern Med 2002, 137:1013-1014 12484737
43. Lukasewitz P Kroh U Löwenstein O Krämer M Lennartz H Quantitative Untersuchungen zur Gewebsspeicherung von mittelmolekularer Hydroxyethylstärke 200/0,5 bei Patienten mit Multiorganversagen J Anaesth Intensivbeh 1998, 3:42-46
44. van Rijen EA Ward JJ Little RA Effects of colloidal resuscitation fluids on reticuloendothelial function and resistance to infection after hemorrhage Clin Diagn Lab Immunol 1998, 5:543-549 95615 9665964
45. Shatney CH Chaudry IH Hydroxyethylstarch administration does not depress reticuloendothelial function or increase mortality from sepsis Circ Shock 1984, 13:21-26 6202435
46. Barron ME Wilkes MM Navickis RJ A systematic review of the comparative safety of colloids Arch Surg 2004, 139:552-563 10.1001/ archsurg.139.5.552 15136357
47. Bork K Pruritus precipitated by hydroxyethyl starch: A review Br J Dermatol 2005, 152:3-12 10.1111/j.1365-2133.2004.06272.x 15656795
48. Davidson IJ Renal impact of fluid management with colloids: A comparative review Eur J Anaesthesiol 2006, 23:721-738 10.1017/ S0265021506000639 16723059
49. Wiedermann CJ Renal failure in septic patients receiving hydroxyethyl starch Minerva Anestesiol 2007, 73:441 17637590
50. Boldt J Brenner T Lehmann A Lang J Kumle B Werling C Influence of two different volume replacement regimens on renal function in elderly patients undergoing cardiac surgery: Comparison of a new starch preparation with gelatin Intensive Care Med 2003, 29:763-769 12665995
51. Winkelmayer WC Glynn RJ Levin R Avorn J Hydroxyethyl starch and change in renal function in patients undergoing coronary artery bypass graft surgery Kidney Int 2003, 64:1046-1049 10.1046/j.1523-1755.2003.00186.x 12911555